NKTR Message Board Post 9266544 | Nektar Therapeutics
home / stock / nktr / nktr message board
keven
(investorshub)
Posted on: Nov/09/2018 23:46:10
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144793599
SITC dataMelanoma PIVOT-02 ORR=53%* (20*/38)24% (9/38) CRs:
News, Short Squeeze, Breakout and More Instantly...
-
Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024 PR Newswire – NKTR-0165 Demonstrates Selective Enhancement of Treg Cell Function Through Novel Agonistic ...
-
Nektar Management to Present at Upcoming Investor Conferences PR Newswire SAN FRANCISCO , May 30, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at upcoming investor conferences: Jefferies Healthcare C...
-
Nektar Therapeutics Reports First Quarter 2024 Financial Results PR Newswire SAN FRANCISCO , May 9, 2024 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2024 . Cash and ...